Re: Goldberg et al.: A phase 3, randomized, double-masked study of OTX-101 ophthalmic solution 0.09% in the treatment of dry eye disease (Ophthalmology. 2019;126:1230-1237)
- PMID: 32564819
- DOI: 10.1016/j.ophtha.2020.01.047
Re: Goldberg et al.: A phase 3, randomized, double-masked study of OTX-101 ophthalmic solution 0.09% in the treatment of dry eye disease (Ophthalmology. 2019;126:1230-1237)
Comment in
-
Reply.Ophthalmology. 2020 Jul;127(7):e43-e44. doi: 10.1016/j.ophtha.2020.01.048. Ophthalmology. 2020. PMID: 32564818 No abstract available.
Comment on
-
A Phase 3, Randomized, Double-Masked Study of OTX-101 Ophthalmic Solution 0.09% in the Treatment of Dry Eye Disease.Ophthalmology. 2019 Sep;126(9):1230-1237. doi: 10.1016/j.ophtha.2019.03.050. Epub 2019 Apr 6. Ophthalmology. 2019. PMID: 30965064 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
